Skip to content
Use caution Drug recall · FDA · Published March 4, 2024

Par Sterile Products Recalls Treprostinil Injection Due to Particulate Matter Risk

Par Sterile Products recalls Treprostinil Injection 20 mg/20 mL vials due to potential particulate matter. This could cause serious complications during infusion. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0429-2024DrugPar Sterile Products ›
Take action

Contact the company

Recalling firmPar Sterile Products LLC870 Parkdale Rd · Rochester, MI 48307-1740
✎ GovInfoNow plain-language explainer

Par Sterile Products is recalling Treprostinil Injection vials because they may contain particulate matter. This could lead to serious complications if the medication is administered. The recall affects specific vial lots and expiration dates. Read more at govinfonow.com/recall/32783-par-sterile-products-recalls-treprostinil-injection-due-to-particulate-matter.

Source Summary by GovInfoNow · govinfonow.com/recall/32783-par-sterile-products-recalls-treprostinil-injection-due-to-particulate-matter · Updated September 23, 2026 · FDA enforcement record: FDA #D-0429-2024

Cite this page

“Par Sterile Products Recalls Treprostinil Injection Due to Particulate Matter Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32783-par-sterile-products-recalls-treprostinil-injection-due-to-particulate-matter. Based on FDA recall #D-0429-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0429-2024%22&limit=1).

Par Sterile Products LLC voluntarily recalled Treprostinil Injection due to the presence of particulate matter, according to the FDA. The Food and Drug Administration announced the Class I recall on March 4, 2024.

How to tell if you have it

  • Brand: Par Sterile Products
  • Product: Treprostinil Injection, 20 mg/20 mL (1 mg/mL)
  • NDC: 42023-206-01
  • Lot#: 57014
  • Expiration: 04/30/2024

The hazard

The recall addresses the presence of particulate matter in the drug product. The FDA classified this as a Class I recall, indicating a high risk of adverse health consequences.

Context

GovInfoNow's records show Par Sterile Products LLC has issued three other recalls since April 28, 2017. On January 11, 2024, the company recalled Vasostrict Injection due to superpotent drug risk, and on November 9, 2021, it recalled Buprenorphine Injections because of crystallization risks. Other recent recalls of similar products include Sunny Pharmtech Cyclophosphamide Injection (July 17, 2026) and American Regent Papaverine HCl Injection (July 24, 2026).

How to tell if you have this one

Check the vial label for the product name, 'Treprostinil Injection, 20 mg/20 mL (1 mg/mL)'. Look for the lot number 57014 and expiration date 04/30/2024.

  • Brand
    Par Sterile Products
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Details

    Identify the lot number and expiration date on the vial label to confirm if it matches the recalled batch.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 30 days after the firm started it.

1. Firm started the recall: Mar 4, 202412. FDA classified it Class I: Mar 28, 202423. Published in FDA’s Enforcement Report: Apr 3, 202432024
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0429-2024 (March 4, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0429-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA